|[November 09, 2012]
KYTHERA Biopharmaceuticals to Present at Lazard Capital Markets 9th Annual Healthcare Conference
LOS ANGELES --(Business Wire)--
Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced that Keith
Leonard, President and Chief Executive Officer, will present a corporate
overview at the Lazard Capital Markets 9th Annual Healthcare Conference
in New York City.
Event: Lazard Capital Markets 9th Annual Healthcare Conference,
New York City
Date: Wednesday, November 14, 2012
9:00 a.m. ET
A live webcast will be availble on the Company's website at www.kytherabiopharma.com
under the Investors section. The presentation will be archived on the
website and will be available for 14 days.
About KYTHERA Biopharmaceuticals, Inc.
KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical
company focused on the discovery, development and commercialization of
novel prescription products for the aesthetic medicine market. KYTHERA's
product candidate, ATX-101, is a potential first-in-class, injectable
treatment currently in Phase III clinical development for the reduction
of submental fat, which commonly presents as an undesirable "double
chin." KYTHERA also maintains an active research interest in hair and
fat biology, pigmentation modulation and facial contouring. Find more
information at http://www.kytherabiopharma.com.
[ Back To TMCnet.com's Homepage ]